- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
Agendia scans for Nasdaq IPO
Norgine, Axa and Debiopharm are in line for exits as the breast cancer diagnostics test provider is aiming to go public to boost research and development and commercial activities.
Nov 2, 2021Aculys Pharma accepts SoftBank-led round
SoftBank’s Vision Fund 2 led a $59.7m round which will support Aculys in bringing a sleep disorder medication it has licensed to Japan.
Nov 2, 2021Daily Deal Round Up: November 1, 2021
Cell therapy developer Hopstem completed a $40m Eli Lilly-backed series B round while cybersecurity technology developer SlashNext secured $26m from investors including Telia and Ayala Group.
Nov 1, 2021Entrada Therapeutics enters Nasdaq
The Merck & Co and Roche-backed Duchenne muscular dystrophy drug developer has gone public in an upsized IPO sized at approximately $182m.
Nov 1, 2021Sonendo scores $94m in IPO
Henry Crown and Company achieved an exit as the root canal technology developer listed on the New York Stock Exchange below its IPO range.
Nov 1, 2021Aura Biosciences soars to public markets
Chiesi, Lundbeck and Li-Cor Biosciences scored exits as the oncology therapy developer floated in an upsized $75.6m initial public offering.
Nov 1, 2021Analysis: Fabric fulfils $200m series C round
E-commerce fulfilment technology provider Fabric closed a series C round, backed by Koch Industries and Harel Insurance and Finance. This is one of the latest sizeable rounds in the still booming e-commerce space.
Nov 1, 2021Daily Deal Round Up: October 29, 2021
Wells Fargo Strategic Capital took part in a $52.5m round for digital mortgage platform developer Maxwell while corporate-backed music distributor UnitedMasters closed a $50m series C.
Oct 29, 2021Wego Interventional takes care with series A
Wego’s interventional equipment subsidiary has secured a nine-digit dollar amount from a host of investors including China Construction Bank’s CCB International vehicle.
Oct 29, 2021Cardurion to capture up to $300m
The Takeda-backed cardiovascular therapeutics developer has agreed up to $300m in fresh funding from Bain Capital Life Sciences and Bain Capital Private Equity.
Oct 28, 2021Immunai imports $215m in series B funding
The Dexcel Pharma-backed immunotherapy discovery technology developer’s latest round was led by Koch Disruptive Technologies and took its overall funding to $295m.
Oct 28, 2021Truepill swallows $142m in series D round
The Optum-backed medical consumer engagement platform increased its total funding to $256m in a round valuing it at $1.6bn.
Oct 28, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
